Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April 8, 2022

Rhea-AI Summary

Biofrontera Inc. (Nasdaq: BFRI) announced it will report its financial results for Q4 and the full year ended December 31, 2021, on April 8, 2022, prior to the opening of U.S. markets. The company will host a conference call at 11:00 a.m. ET the same day to discuss these results and provide a business update.

The call can be accessed through a toll-free number for U.S. participants and an international line. A webcast of the call will also be available for live viewing and a 90-day replay.

Positive

• Scheduled release of Q4 and full-year financial results could provide clarity on business performance.
• Conference call allows for direct communication with investors, potentially increasing investor confidence.

Negative

• None.

WOBURN, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today it will report financial results for the three months and full year ended December 31, 2021 before the opening of the U.S. financial markets on Friday, April 8, 2022 and will host a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions.

Conference Call and Webcast Information

Event:	Biofrontera Inc. Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call
Date:	Friday, April 8, 2022
Time:	11:00 a.m. Eastern time
Conference call:	1-877-877-1275 (U.S.) 1-412-858-5202 (international)
Webcast:	Live and 90-day replay webcast are available here and at www.investors.biofrontera-us.com.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on PDT and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit https://www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

FAQ

When will Biofrontera report its financial results for 2021?

Biofrontera will report its financial results for the year ended December 31, 2021, on April 8, 2022.

What is the time for the Biofrontera conference call?

The conference call is scheduled for April 8, 2022, at 11:00 a.m. Eastern time.

How can I access the Biofrontera conference call?

The conference call can be accessed by dialing 1-877-877-1275 (U.S.) or 1-412-858-5202 (international).

Will there be a webcast for the Biofrontera conference call?

Yes, a live webcast and a 90-day replay will be available on Biofrontera's investor relations website.

What financial results will Biofrontera discuss on April 8, 2022?

Biofrontera will discuss its financial results for Q4 and the full year ended December 31, 2021.